AdoRx Therapeutics secures initial funding of USD10m for discovery of new cancer therapeutics
AdoRx Therapeutics, a UK based drug discovery company focused on the identification of new cancer therapeutics, has closed an initial USD10 million investment round financed by Epidarex Capital and CRT Pioneer Fund (CPF). AdoRx was founded in 2017 by leading healthcare investor Epidarex Capital and has assembled a group of
